These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 101467)

  • 1. Role of nonagglutinating antibody in the protracted immunity of vaccinated mice to Pseudomonas aeruginosa infection.
    Moody MR; Kessel RW; Young VM; Fiset P
    Infect Immun; 1978 Sep; 21(3):905-13. PubMed ID: 101467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis antibodies in the sera of children exposed to Bordetella pertussis by vaccination or infection.
    Dolby JM; Stephens S
    J Hyg (Lond); 1973 Mar; 71(1):193-207. PubMed ID: 4348456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive protective properties of serum fractions from mice inoculated with an anti-pseudomonas vaccine.
    Jones RJ; Hall M; Ricketts CR
    Immunology; 1972 Dec; 23(6):889-95. PubMed ID: 4630781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. II. Opsonic, agglutinative, and protective capacities of immunoglobulin G anti-Pseudomonas antibodies.
    Bjornson AB; Michael JG
    Infect Immun; 1972 May; 5(5):775-82. PubMed ID: 4629252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The changes of the OEP-HA titer in the sera of mice challenged with Pseudomonas aeruginosa and in the phagocytic system of macrophages in vitro (author's transl)].
    Satomi N; Haranaka K; Kunii O; Mashimo K
    Kansenshogaku Zasshi; 1979 Aug; 53(8):350-8. PubMed ID: 119815
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent Pseudomonas vaccine.
    Jones RJ; Roe EA
    Br J Exp Pathol; 1975 Feb; 56(1):34-43. PubMed ID: 812544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
    APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of antibody in infections due to Pseudomonas aeruginosa.
    Young LS
    J Infect Dis; 1974 Nov; 130 Suppl(0):S111-8. PubMed ID: 4213568
    [No Abstract]   [Full Text] [Related]  

  • 10. Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa.
    Penketh AR; Pitt TL; Hodson ME; Batten JC
    J Med Microbiol; 1983 Nov; 16(4):401-8. PubMed ID: 6417338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-linked immunosorbent assay for detection of antibody to Pseudomonas aeruginosa and measurement of antibody titer in horse serum.
    Ueda Y; Sanai Y; Homma JY
    Am J Vet Res; 1982 Jan; 43(1):55-60. PubMed ID: 6807144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type-specific indirect hemagglutinating antibody in patients with Pseudomonas aeruginosa Infection.
    Shigeta S; Yasunaga Y; Ogata M
    J Clin Microbiol; 1978 Nov; 8(5):489-95. PubMed ID: 103887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
    Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
    Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antibody and ocular responses to murine corneal infection caused by Pseudomonas aeruginosa.
    Berk RS; Montgomery IN; Hazlett LD
    Infect Immun; 1988 Dec; 56(12):3076-80. PubMed ID: 3141279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycolipoprotein from Pseudomonas aeruginosa as a protective antigen against P. aeruginosa infection in mice.
    Sensakovic JW; Bartell PF
    Infect Immun; 1977 Nov; 18(2):304-9. PubMed ID: 411754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
    Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M
    Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
    Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
    J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibody response to Pseudomonas aeruginosa antigens during corneal infection.
    Preston MJ; Berk JM; Hazlett LD; Berk RS
    Infect Immun; 1991 Jun; 59(6):1984-90. PubMed ID: 1903770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological nonidentity of Pseudomonas paucimobilis with Pseudomonas aeruginosa and Pseudomonas cepacia.
    Smalley DL; Ourth DD
    J Clin Microbiol; 1980 Sep; 12(3):439-41. PubMed ID: 6783679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
    Priebe GP; Walsh RL; Cederroth TA; Kamei A; Coutinho-Sledge YS; Goldberg JB; Pier GB
    J Immunol; 2008 Oct; 181(7):4965-75. PubMed ID: 18802100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.